Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial.
Nuki G, Bresnihan B, Bear MB, McCabe D; European Group Of Clinical Investigators. Nuki G, et al. Among authors: bear mb. Arthritis Rheum. 2002 Nov;46(11):2838-46. doi: 10.1002/art.10578. Arthritis Rheum. 2002. PMID: 12428223 Free article. Clinical Trial.
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
Cohen SB, Moreland LW, Cush JJ, Greenwald MW, Block S, Shergy WJ, Hanrahan PS, Kraishi MM, Patel A, Sun G, Bear MB; 990145 Study Group. Cohen SB, et al. Among authors: bear mb. Ann Rheum Dis. 2004 Sep;63(9):1062-8. doi: 10.1136/ard.2003.016014. Epub 2004 Apr 13. Ann Rheum Dis. 2004. PMID: 15082469 Free PMC article. Clinical Trial.
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, Kremer J, Bear MB, Rich WJ, McCabe D. Cohen S, et al. Among authors: bear mb. Arthritis Rheum. 2002 Mar;46(3):614-24. doi: 10.1002/art.10141. Arthritis Rheum. 2002. PMID: 11920396 Free article. Clinical Trial.
A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Ménière's disease.
Lambert PR, Nguyen S, Maxwell KS, Tucci DL, Lustig LR, Fletcher M, Bear M, Lebel C. Lambert PR, et al. Among authors: bear m. Otol Neurotol. 2012 Sep;33(7):1257-65. doi: 10.1097/MAO.0b013e318263d35d. Otol Neurotol. 2012. PMID: 22858715 Clinical Trial.
Phase 3 Trials of Thermosensitive Ciprofloxacin Gel for Middle Ear Effusion in Children with Tubes.
Park AH, White DR, Moss JR, Bear M, LeBel C. Park AH, et al. Among authors: bear m. Otolaryngol Head Neck Surg. 2016 Aug;155(2):324-31. doi: 10.1177/0194599816645526. Epub 2016 May 17. Otolaryngol Head Neck Surg. 2016. PMID: 27188702 Free PMC article. Clinical Trial.
Safety and Efficacy of Intratympanic Ciprofloxacin Otic Suspension in Children With Middle Ear Effusion Undergoing Tympanostomy Tube Placement: Two Randomized Clinical Trials.
Mair EA, Park AH, Don D, Koempel J, Bear M, LeBel C. Mair EA, et al. Among authors: bear m. JAMA Otolaryngol Head Neck Surg. 2016 May 1;142(5):444-51. doi: 10.1001/jamaoto.2016.0001. JAMA Otolaryngol Head Neck Surg. 2016. PMID: 26985629 Clinical Trial.
Randomized Clinical Trial of a Sustained-Exposure Ciprofloxacin for Intratympanic Injection During Tympanostomy Tube Surgery.
Mair EA, Moss JR, Dohar JE, Antonelli PJ, Bear M, LeBel C. Mair EA, et al. Among authors: bear m. Ann Otol Rhinol Laryngol. 2016 Feb;125(2):105-14. doi: 10.1177/0003489415599001. Epub 2015 Aug 20. Ann Otol Rhinol Laryngol. 2016. PMID: 26296929 Free PMC article. Clinical Trial.
A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers.
Mustoe TA, Cutler NR, Allman RM, Goode PS, Deuel TF, Prause JA, Bear M, Serdar CM, Pierce GF. Mustoe TA, et al. Among authors: bear m. Arch Surg. 1994 Feb;129(2):213-9. doi: 10.1001/archsurg.1994.01420260109015. Arch Surg. 1994. PMID: 8304833 Clinical Trial.
Phase 1 safety trial of Filgrastim (r-metHuG-CSF) in non-neutropenic patients with severe community-acquired pneumonia.
deBoisblanc BP, Mason CM, Andresen J, Logan E, Bear MB, Johnson S, Shellito J, Summer WR, Nelson S. deBoisblanc BP, et al. Among authors: bear mb. Respir Med. 1997 Aug;91(7):387-94. doi: 10.1016/s0954-6111(97)90250-x. Respir Med. 1997. PMID: 9327037 Free article. Clinical Trial.
Time to resolution of morbidity: an endpoint for assessing the clinical cure of community-acquired pneumonia.
Daifuku R, Movahhed H, Fotheringham N, Bear MB, Nelson S. Daifuku R, et al. Among authors: bear mb. Respir Med. 1996 Nov;90(10):587-92. doi: 10.1016/s0954-6111(96)90016-5. Respir Med. 1996. PMID: 8959115 Free article. Clinical Trial.
15 results
Jump to page
Feedback